Piribo: Drug Safety for Marketed Drugs, new publication announcement

Safety surveillance has much to offer as a powerful knowledge-based tool capable of defending company products in the marketplace while conducting its primary function of safeguarding public health. However, this asset is not translating much beyond the cloistered walls of its practitioners in industry and health authorities.

Clearly, a formidable arsenal has been developed over time: a scientific conceptual base, legislation, data systems, sophisticated technological support
- hard- and software
- monitoring and analytical systems, quality controls with audit and inspection, and communication tools. The eyeforpharma conference on Drug Safety for Marketed Drugs, held in Amsterdam on 22-23 November 2005, demonstrated that, as a whole, this arsenal works. And yet there is a lack of awareness of its impact where it matters
- the end user (the medical practitioner and patient).
This KeywordPharma Conference Insights review, published by NetworkPharma Ltd, comprises the highlights of a selection of presentations from the eyeforpharma conference, providing a platform for how and where the industry can improve drug safety. Crucially, it also outlines how companies can communicate the true and undoubted value of safety surveillance.

“Drug Safety for Marketed Drugs” is available from Piribo. For more information go to: http://www.piribo.com/publications/sales_marketing/drug_safety_marketed_drugs.html

Piribo Product ID: NWP002

About Piribo.
Piribo (http://www.piribo.com) is a UK-based independent online store supplying business information on the pharmaceutical and biotechnology industries. The website now carries over 3,800 English language titles including, market reports, studies and books and is the UK’s largest online biopharma information store. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. The company was established in 2004.